News

Venaxis Announces Regulatory and Market Development Progress

Venaxis, Inc. will host an investor conference call to discuss business updates, including discussion on the progress of its APPY1 FDA submission, commercial and marketing progress and next-generation product development.  Read more…



Venaxis to Provide Business Update, including FDA Submission Update

Venaxis, Inc. today announced it will provide a business update, including discussion on the progress of the APPY1 FDA submission, on Monday, August 11, 2014, at 8:30 a.m. ET. The conference call will be hosted by Steve Lundy, President and CEO.  Read more…



Venaxis to Present at Canaccord Genuity 34th Annual Growth Conference

Venaxis, Inc. today announced it will present at the Canaccord Genuity 34th Annual Growth Conference, to be held August 13-14, 2014, at the Intercontinental Boston in Boston, MA.  Read more…